US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine
Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...
ETF Daily News2d
Bavarian Nordic A/S (OTCMKTS:BVNRY) Share Price Passes Below 200 Day Moving Average – Time to Sell?
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
Bavarian Nordic’s Jynneos highlights unmet need for mpox prevention in HIV patients
This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing ...
CIDRAP3d
FDA approves freeze-dried version of Jynneos mpox vaccine
Yesterday the US Food and Drug Administration (FDA) approved a freeze-dried formulation of Bavarian Nordic's mpox vaccine, ...
The Pharma Letter13h
Research shows need for better mpox protection in HIV-positive patients
A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...
European shares recover ground as markets brace for US tariff deadline
European shares rebounded on Tuesday from a two-month low touched in the previous session, while the market braced for an ...
Explore more
Pharmaceutical Technology on MSN3d
FDA approves Bavarian Nordic’s freeze-dried mpox and smallpox vaccine
The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US government to add to vaccine ...
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine
The Company has been contracted by the U.S Biomedical Advanced Research and Development Authority (BARDA) to develop and supply a freeze-dried version of JYNNEOS for stockpiling. Manufacturing under ...